In the midst of the Covid-19 surge during the winter of 2021, the Pittsburgh-based UPMC health system received 450 doses of Evusheld — a scarce
NexImmune had reported a significant reduction in its cash reserves in the last six months. Image Credit: DesignPrax / Shutterstock. NexImmune became the latest in
Scitegrity, a leading company in chemical regulatory compliance, is excited to announce the expanded release of its Dangerous Goods Assessor for Pharmaceutical Process Development and
Big Pharma has certainly taken note of the potential therapeutic benefits of psychedelics. Otsuka, a major Japanese Pharmaceutical company, recently signed an agreement to acquire
After months of legal sparring, Amgen and Horizon Therapeutics settled a lawsuit with the Federal Trade Commission that will allow the company to proceed with
Amgen today announced data from the final analysis of the Phase 2 OCEAN(a)-DOSE study of olpasiran, a small interfering RNA (siRNA) during the Late-Breaking Science Session
Amgen today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) will review data supporting the supplemental New Drug Application (sNDA) for the
As we described in a previous article, the Global Cannabis Stock Index rallied for the second consecutive month on a huge late-month surge. That index is now down
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal
Postnatal dietary patterns, physical activity status, and changes in body weight among obese women living in a highly deprived region in the UK.